Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03607448 · ClinicalTrials.gov registry record
Freestyle Libre Flash Glucose Monitoring System
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 153
- Enrollment target
NCT03607448: Completed study, sponsored by Abbott Diabetes Care.
NCT03607448 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03607448 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the Freestyle Libre Flash Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.
Primary Outcome
System Performance will be characterized with respect to YSI reference venous plasma measurements
Interventions
- DEVICE Freestyle Libre Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2018-11-21 |
What the finished NCT03607448 record still lists
NCT03607448 is an observational study that tracks outcomes without assigning an intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Freestyle Libre Flash Glucose Monitoring System is the first listed.
NCT03607448 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03607448 about?
NCT03607448 is a clinical study titled "Freestyle Libre Flash Glucose Monitoring System". The purpose of this study is to characterize the Freestyle Libre Flash Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.
What is the current status of trial NCT03607448?
This trial is currently completed. The enrollment target is 153 participants. The study started on 2018-07-23. Estimated completion is 2018-11-21.
What interventions are being tested in trial NCT03607448?
The interventions under investigation include: Freestyle Libre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03607448?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI